St. Jude Medical Announces CE Mark Approval And FDA Clearance For New Family Of HIFU Surgical Ablation Products

in

St. Jude Medical, Inc. (NYSE:STJ) has received European CE Mark approval and U.S. Food and Drug Administration (FDA) clearance for the Epicor(TM) LP Cardiac Ablation System, a second generation technology that uses HIFU (high intensity focused ultrasound) to surgically ablate cardiac tissue to disrupt abnormal electrical impulses in the heart.